JEFFREY MOFFAT: Open Payments
NPI 1144545948 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 15 payments from 6 companies in 2025. Trend: 2023 $137 · 2024 $397 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $167 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: AUSTEDO XR, INGREZZA, CAPLYTA, REXULTI, UZEDY, VRAYLAR.
Industry payments across CA — which companies pay providers there.
